EMILY SCHOFIELD: Open Payments
NPI 1790107548 · WATKINSVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,859 in 101 payments from 14 companies in 2025. Trend: 2023 $1,711 · 2024 $2,293 · 2025 $1,859
Food & beverage: $1,859
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 53 | $903 |
| Novartis Pharmaceuticals Corporation | 10 | $217 |
| UCB, Inc. | 11 | $185 |
| Amgen Inc. | 10 | $180 |
| PFIZER INC. | 5 | $109 |
| E.R. Squibb & Sons, L.L.C. | 2 | $49 |
| Janssen Biotech, Inc. | 2 | $40 |
| Aurinia Pharma U.S., Inc. | 2 | $32 |
| Boston Scientific Corporation | 1 | $31 |
| GENZYME CORPORATION | 1 | $27 |
Products named: RINVOQ, SKYRIZI, COSENTYX, Bimzelx, XELJANZ, EVENITY, KRYSTEXXA, ORENCIA.
Industry payments across GA — which companies pay providers there.
